Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Ecolab (ECL) Misses Q4 Earnings Estimates, View Impressive

Published 02/20/2018, 04:22 AM
Updated 07/09/2023, 06:31 AM

Ecolab Inc. (NYSE:ECL) reported fourth-quarter 2017 adjusted earnings of $1.39 per share, which missed the Zacks Consensus Estimate by a penny. Earnings improved from $1.25 in the year-ago quarter.

Ecolab carries a Zacks Rank #3 (Hold).

Including net discrete tax benefit from U.S. Tax Reform of 55 cents per share, Ecolab registered earnings of $1.93 on reported basis.

Adjusted quarterly net sales were $3.56 billion, up 7.2% from the year-ago quarter. Also, net sales missed the Zacks Consensus Estimate of $3.62 billion.

Ecolab Inc. Price, Consensus and EPS Surprise

Segmental Analysis

Global Industrial Segment

Sales in the segment grew 6.1% year over year to almost $1.29 billion. The upside was driven by major gains in Water, Food & Beverage and Life Sciences unit.

Europe, North America and Latin America led the Global Industrial regional growth. Acquisition-adjusted fixed currency operating income improved 4% on a year-over-year basis.

Global Institutional Segment

Sales increased 8.5% to $1.22 billion, led by strong growth in the Specialty business line. The segment witnessed solid growth in North America and Asia Pacific.

Acquisition-adjusted fixed currency operating income remained flat year over year.

Global Energy Segment

Sales rose 10.8% to $853.2 million owing to strong growth in the well stimulation business and modest gains in the downstream business.

Acquisition-adjusted fixed currency operating income increased 4% year over year.

Other Segment

Sales declined 6.8% year over year to $189.7 million. Sales in this segment witnessed robust growth in North America.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Margin Analysis

As a percentage of revenues, Ecolab registered adjusted gross margin of 47.1% in the fourth quarter, down 100 basis points (bps) on a year-over-year basis.

Adjusted operating margin in the fourth quarter contracted 70 bps to to 16.2% of net revenues.

Outlook

Ecolab expects full-year 2018 adjusted earnings in the range of $5.25-$5.45 per share, up 12-16% year over year.

As a percentage of revenues, adjusted gross margin is expected in the range of 47-48%.

For the first quarter of 2018, Ecolab expects adjusted earnings in the range of 85-93 cents per share, up from the previous range of 84-92 cents. The current outlook reflects an increase of 6-16% year over year.

Adjusted Gross Margin for the first quarter of 2018 is expected to be 46% of net revenues.

Our Take

Ecolab ended the fourth quarter on an unfavorable note, missing the Zacks Consensus Estimate on both the counts. Despite strength in Pest Elimination business, the Other segment declined year over year on reported basis. Ecolab operates in highly competitive markets, which might mar prospects over the long haul.

We believe that volatility in foreign currency exchange rates will remain a significant headwind for the company. Ecolab faces pricing pressure in the Energy segment which is likely to hurt profits.

On the brighter side, a strong guidance instills optimism on the stock. Further, Europe, North America and Latin America led the Global Industrial regional growth in the quarter. Strength in the Global Institutional segment led by growth in the Specialty and Healthcare business lines is also a positive. A robust product portfolio and expanding customer base is likely to drive organic sales over the long haul.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Key Picks

A few better-ranked stocks that reported solid results this earnings season are PetMed Express (NASDAQ:PETS) , PerkinElmer (NYSE:PKI) and Becton, Dickinson and Company (NYSE:BDX) . While PetMed sports a Zacks Rank #1 (Strong Buy), PerkinElmer and Becton, Dickinson carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

PetMed reported third-quarter fiscal 2018 adjusted earnings per share of 44 cents, up 88.3% from the prior-year quarter. Revenues rose 13.7% to $60.1 million.

PerkinElmer posted fourth-quarter 2017 adjusted earnings per share of 97 cents. Adjusted revenues were approximately $641.6 million, up from $567 million in the year-ago quarter.

Becton, Dickinson reported first-quarter fiscal 2018 adjusted earnings per share of $2.48, up 3.9% at constant currency. Revenues totaled $3.08 billion, up 3.7% at constant currency.

Can Hackers Put Money INTO Your Portfolio?

Earlier this month, credit bureau Equifax (NYSE:EFX) announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.

Zacks has just released Cybersecurity! An Investor’s Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.

Download the new report now>>



PetMed Express, Inc. (PETS): Free Stock Analysis Report

Ecolab Inc. (ECL): Free Stock Analysis Report

PerkinElmer, Inc. (PKI): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Becton, Dickinson and Company (BDX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.